Cowen And Company, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $2.68 Million - $3.26 Million	-37,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $2.79 Million - $3.48 Million	37,500 New	37,500 $94,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $1.03 Million - $1.18 Million	-13,800 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $90,612 - $101,748	-1,200 Reduced 8.0%	13,800 $38,000
Q1 2021 May 04, 2021	SELL	$74.73 - $90.69 $687,516 - $834,348	-9,200 Reduced 38.02%	15,000 $153,000
Q4 2020 Feb 08, 2021	BUY	$72.61 - $90.2 $1.08 Million - $1.34 Million	14,900 Added 160.22%	24,200 $33,000
Q3 2020 Nov 03, 2020	BUY	$71.87 - $131.03 $668,391 - $1.22 Million	9,300 New	9,300 $40,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.